Teacher

Amanda Feilding



Amanda Feilding, Countess of Wemyss and March, is an English drug policy reformer, lobbyist, and research coordinator known for her work in the field of psychedelic science. As founder of the Beckley Institute (formerly the Foundation to Further Consciousness), her work focuses on researching the potential harms and benefits of psychoactive substances and exploring how they can be used to cure sickness and enhance wellbeing.

Amanda Feilding
FindCenter Video Image
24:21

Amanda Feilding: The Beckley Foundation’s Program of Psychedelic Research

Psychedelics afford a unique opportunity to expand our understanding of consciousness and its altered states, to develop techniques for enhancing consciousness, and to uncover new avenues of treatment and improved therapeutic techniques.

FindCenter AddIcon
FindCenter Video Image

The Coming of Age of LSD

It seems amazing that something so totally personal as ones level of consciousness could be considered an illegal act. But there is a turning of the tide both in policy and in scientific research, which has begun to recognise the value of these substances.

FindCenter AddIcon
FindCenter Video Image

The Future of Psychedelic Medicine

This is an exciting time to be involved in psychedelic research. Medical researchers are rediscovering the possible benefits of responsible use of psychedelics in therapeutic settings.

FindCenter AddIcon
FindCenter Video Image
01:11:17

Opening Plenary: Rick Doblin, Amanda Feilding & Beatriz Labate

Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.

FindCenter AddIcon
FindCenter Video Image

Hofmann’s Elixir: LSD and the New Eleusis

Still lecturing until his death at 102, Dr Albert Hofmann would have been a remarkable man even if he hadn't discovered the chemical compound that changed the course of the 20th century—LSD.

FindCenter AddIcon
FindCenter Video Image
34:30

Amanda Feilding: LSD, Precious Key of Neuroscience | The Beckley Foundation

The Beckley Foundation Scientific Program conducts cutting edge research with LSD in human subjects, explores neurophysiological similarities between LSD and the mystical experience through observing modulations in the blood supply, brainwaves and a broad spectrum of cognitive changes.

FindCenter AddIcon
FindCenter Video Image

New Studies Just Found Psychedelics Help Terminal Cancer Patients and Could Be the New Wonder Drugs for Psychiatry—They Shouldn’t Be Ignored

The active ingredient in magic mushrooms was given to terminal cancer patients: 80 per cent had immediate reductions in anxiety and depression which persisted for six months or longer.

FindCenter AddIcon
FindCenter Video Image
17:43

Amanda Feilding for LSD75 - 'From Problem Child to Wonder Child: An Evolving Story..'

On Bicycle Day 2018, Amanda Feilding addressed the LSD75.CH Symposium in Basel. In her speech, 'From Problem Child to Wonder Child: An Evolving Story.', she reflects on her memories of Albert Hofmann, her research into psychedelic medicines, and the future she envisions for LSD.

FindCenter AddIcon
FindCenter Video Image

The New Year Is Prime Time for Unnecessary Drug-Related Deaths – Legalising MDMA Could Stop Them

As someone who’s been fighting for reform for over 20 years, I know a regulated market and a deeper understanding of substances would go a long way towards mitigating the risks.

FindCenter AddIcon
FindCenter Video Image

Psychedelic Science Should Not Be Feared, It Should Be Encouraged

The Home Office has repeatedly stated the substances' scheduling does not impede the development of this type of research; and yet, time and time again the current system has led us to financial and logistic hurdles.

FindCenter AddIcon
FindCenter Loader Image

UP NEXT

Rick Doblin